DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 39 filers reported holding DIAMEDICA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 3.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,810 | -40.7% | 1,570 | 0.0% | 0.00% | – |
Q2 2023 | $8,114 | +161.4% | 1,570 | 0.0% | 0.00% | – |
Q1 2023 | $3,104 | +6.8% | 1,570 | 0.0% | 0.00% | – |
Q4 2022 | $2,906 | +20.6% | 1,570 | 0.0% | 0.00% | – |
Q3 2022 | $2,410 | -38.1% | 1,570 | 0.0% | 0.00% | – |
Q2 2022 | $3,892 | -16.8% | 1,570 | 0.0% | 0.00% | – |
Q1 2022 | $4,677 | -43.9% | 1,570 | -14.7% | 0.00% | – |
Q4 2021 | $8,330 | – | 1,840 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 233,730 | $369,293 | 0.45% |
COOPERMAN LEON G | 812,508 | $1,283,844 | 0.08% |
CATALYST FINANCIAL PARTNERS LLC | 14,475 | $22,872 | 0.01% |
Legend Financial Advisors, Inc. | 1,000 | $1,580 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 184,870 | $292 | 0.00% |
STATE STREET CORP | 133,258 | $210,548 | 0.00% |
MORGAN STANLEY | 55,201 | $87,223 | 0.00% |
BlackRock Inc. | 69,937 | $110,508 | 0.00% |
Bank of New York Mellon Corp | 36,062 | $56,982 | 0.00% |
Citadel Advisors | 1,600 | $2,528 | 0.00% |